Volume 21, Issue 3 (6-2018)
J Arak Uni Med Sci 2018, 21(3): 94-103 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nakhzari Khodakheir J, Haghighi A H, Hamedinia M R. The Effects of Combined Exercise Training with Aerobic Dominant and Coenzyme Q10 Supplementation on Serum BDNF and NGF levels in Patients with Multiple Sclerosis. J Arak Uni Med Sci 2018; 21 (3) :94-103
URL: http://jams.arakmu.ac.ir/article-1-5633-en.html
URL: http://jams.arakmu.ac.ir/article-1-5633-en.html
1- Department of Sport Sciences, Zabol University, Zabol, Iran. , javadnakhzari@uoz.ac.ir
2- Department of Sport Physiology, Hakim Sabzevari University, Sabzevar, Iran.
2- Department of Sport Physiology, Hakim Sabzevari University, Sabzevar, Iran.
Abstract: (3679 Views)
Background and Aim: Physical activity and exercise are as the methods stimulating the secretion of nerve growth factors in MS patients. Therefore, the purpose of this study was to investigate the effects of combined exercise training with aerobic dominant and supplementation of coenzyme Q10 on serum BDNF and NGF levels in patients with multiple sclerosis.
Materials and Methods: In the semi-experimental research, twenty-eight MS patients (EDSS=3-5) were selected by using available sampling method and randomly divided into three experimental groups (combined exercise training + Q10 supplementation, combined exercise training + placebo, and Q10 supplementation) and one control group. two experimental groups performed a combined exercise program include two sessions of aerobic training and one session of resistance training three sessions per week for eight weeks. 200 mg of Q10 supplement was prescribed per day. Blood samples (after 10 hours fasting) were collected 24 hours before the first and 24 hours after the last session of exercise for evaluation of serum levels of BDNF and NGF. Data were analyzed with analysis of covariance at a significance level of p<0.05.
Findings: The results showed no significant changes in serum levels of BDNF and NGF in the three experimental groups compared to the control group (p≥0.05).
Conclusion: Combined exercise training with coenzyme Q10 supplementation cannot lead to changes in serum concentration of nerve growth factors (BDNF, NGF) in patients with MS. Therefore, it is necessary to change the duration and severity of this type of training as well as dose of Q10 supplementation.
Materials and Methods: In the semi-experimental research, twenty-eight MS patients (EDSS=3-5) were selected by using available sampling method and randomly divided into three experimental groups (combined exercise training + Q10 supplementation, combined exercise training + placebo, and Q10 supplementation) and one control group. two experimental groups performed a combined exercise program include two sessions of aerobic training and one session of resistance training three sessions per week for eight weeks. 200 mg of Q10 supplement was prescribed per day. Blood samples (after 10 hours fasting) were collected 24 hours before the first and 24 hours after the last session of exercise for evaluation of serum levels of BDNF and NGF. Data were analyzed with analysis of covariance at a significance level of p<0.05.
Findings: The results showed no significant changes in serum levels of BDNF and NGF in the three experimental groups compared to the control group (p≥0.05).
Conclusion: Combined exercise training with coenzyme Q10 supplementation cannot lead to changes in serum concentration of nerve growth factors (BDNF, NGF) in patients with MS. Therefore, it is necessary to change the duration and severity of this type of training as well as dose of Q10 supplementation.
Keywords: Brian derived neurotrophic factor, Coenzyme Q10, Combined exercise training, Multiple sclerosis, Nerve growth factor.
References
1. Bansi J, Bloch W, Gamper U, Kesselring J. Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial. Multiple Sclerosis Journal. 2013; 19(5):613-21.
2. Ransohoff RM, Hafler DA, Lucchinetti CF. Multiple sclerosis—a quiet revolution. Nature Reviews Neurology. 2015; 11(3):134.
3. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Annals of neurology. 2007; 61(6):504-13.
4. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Annals of neurology. 2007; 61(4):288-99.
5. Harris VK, Sadiq SA. Disease biomarkers in multiple sclerosis. Molecular diagnosis & therapy. 2009; 13(4):225-44.
6. Ghadampour E, Radmehr P, Yousefvand L. The effectiveness of acceptance and commitment based treatment on social competence and life expectancy of patients with multiple sclerosis. Armaghane danesh. 2017; 21(11):1100-14.
7. Newman M, Dawes H, Van den Berg M, Wade D, Burridge J, Izadi H. Can aerobic treadmill training reduce the effort of walking and fatigue in people with multiple sclerosis: a pilot study. Multiple Sclerosis Journal. 2007; 13(1):113-9.
8. Kjølhede T, Vissing K, Dalgas U. Multiple sclerosis and progressive resistance training: a systematic review. Multiple Sclerosis Journal. 2012; 18(9):1215-28.
9. White LJ, Castellano V. Exercise and Brain Health—Implications for Multiple Sclerosis. Sports medicine. 2008; 38(2):91-100.
10. Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Research Reviews. 1998; 27(1):1-39.
11. Vaynman S, Gomez-Pinilla F. License to run: exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins. Neurorehabilitation and neural repair. 2005; 19(4):283-95.
12. Gold SM, Schulz K-H, Hartmann S, Mladek M, Lang UE, Hellweg R, et al. Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls. Journal of neuroimmunology. 2003; 138(1):99-105.
13. Radak Z, Toldy A, Szabo Z, Siamilis S, Nyakas C, Silye G, et al. The effects of training and detraining on memory, neurotrophins and oxidative stress markers in rat brain. Neurochemistry international. 2006; 49(4):387-92.
14. Castellano V, White LJ. Serum brain-derived neurotrophic factor response to aerobic exercise in multiple sclerosis. Journal of the neurological sciences. 2008; 269(1):85-91.
15. Briken S, Rosenkranz SC, Keminer O, Patra S, Ketels G, Heesen C, et al. Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis. Journal of neuroimmunology. 2016; 299:53-8.
16. Sanoobar M, Eghtesadi S, Azimi A, Khalili M, Jazayeri S, Reza Gohari M. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing–remitting multiple sclerosis. International Journal of Neuroscience. 2013; 123(11):776-82.
17. Sanoobar M, Dehghan P, Khalili M, Azimi A, Seifar F. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: a double blind randomized clinical trial. Nutritional neuroscience. 2016; 19(3):138-43.
18. Mohammadi-Bardbori A, Hosseini M-J. Therapeutic implication of coenzyme Q10 during statin therapy: pros and cons. Trends in Pharmaceutical Sciences. 2015; 1(3):119-28.
19. Hathcock JN, Shao A. Risk assessment for coenzyme Q10 (Ubiquinone). Regulatory Toxicology and Pharmacology. 2006; 45(3):282-8.
20. Littarru GP, Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition. 2010; 26(3):250-4.
21. Schulz K-H, Gold SM, Witte J, Bartsch K, Lang UE, Hellweg R, et al. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. Journal of the neurological sciences. 2004; 225(1):11-8.
22. Griffin ÉW, Mullally S, Foley C, Warmington SA, O'Mara SM, Kelly ÁM. Aerobic exercise improves hippocampal function and increases BDNF in the serum of young adult males. Physiology & behavior. 2011; 104(5):934-41.
23. Church DD, Hoffman JR, Mangine GT, Jajtner AR, Townsend JR, Beyer KS, et al. Comparison of high-intensity vs. high-volume resistance training on the BDNF response to exercise. Journal of Applied Physiology. 2016; 121(1):123-8.
24. Schiffer T, Schulte S, Hollmann W, Bloch W, Strüder H. Effects of strength and endurance training on brain-derived neurotrophic factor and insulin-like growth factor 1 in humans. Hormone and metabolic research. 2009; 41(03):250-4.
25. Correia PR, Scorza FA, da Silva SG, Pansani A, Toscano-Silva M, de Almeida AC, et al. Increased basal plasma brain-derived neurotrophic factor levels in sprint runners. Neuroscience bulletin. 2011; 27(5):325.
26. Dishman RK, Berthoud HR, Booth FW, Cotman CW, Edgerton VR, Fleshner MR, et al. Neurobiology of exercise. Obesity. 2006; 14(3):345-56.
27. Seifert T, Brassard P, Wissenberg M, Rasmussen P, Nordby P, Stallknecht B, et al. Endurance training enhances BDNF release from the human brain. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2009; 298(2): R372-R7.
28. Schmolesky MT, Webb DL, Hansen RA. The effects of aerobic exercise intensity and duration on levels of brain-derived neurotrophic factor in healthy men. Journal of sports science & medicine. 2013; 12(3):502.
29. Samadi A. Exercise Preconditioning and Neuroprotection: A Review of Mechanisms. 2015.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
